title: Which markers of inflammation should be used in therapeutic intervention studies of CB/COAD?
authors.affiliation: Department of Clinical Chemistry, University Hospital, Uppsala, Sweden.
authors.forename: P
authors.initials: P
authors.lastname: Venge
authors.forename: R
authors.initials: R
authors.lastname: Brattsand
authors.forename: L A
authors.initials: LA
authors.lastname: Laitinen
authors.forename: C G
authors.initials: CG
authors.lastname: Persson
mesh_terms: D001991:Bronchitis / Q000473:pathology* / Q000628:therapy; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D002908:Chronic Disease; D006801:Humans; D007249:Inflammation / Q000473:pathology*; D008173:Lung Diseases, Obstructive / Q000473:pathology* / Q000628:therapy